Intensity Therapeutics Inc INTS

$3.38 -0.04 (-1.17%)

Valuation

Market cap
11,166,000
Revenue TTM
$0
Net income TTM
$-11,610,000
PE ratio
0.00
Forward PE
—
Profit margin
0.00%
Debt to equity
0.00

Trading

Volume
8,300
Avg volume
26,482
Day's range
$3.35 – $3.55
Shares out
3,265,000
Stochastic %K
30%
Beta
2.81
Analysts
Strong Sell
Price target
$18.50

Price

Company profile

Intensity Therapeutics, Inc., a late-stage clinical biotechnology company, engages in the provision of treatment for the regional and systemic nature of cancer relapse and metastasis in the United States. Its lead product candidate includes INT230-6, which is in Phase 3 clinical studies for the treatment of soft tissue sarcoma; and neoadjuvant and metastatic triple negative breast cancer which is in Phase 2 clinical...

Show more

Intensity Therapeutics, Inc., a late-stage clinical biotechnology company, engages in the provision of treatment for the regional and systemic nature of cancer relapse and metastasis in the United States. Its lead product candidate includes INT230-6, which is in Phase 3 clinical studies for the treatment of soft tissue sarcoma; and neoadjuvant and metastatic triple negative breast cancer which is in Phase 2 clinical trials. The company was incorporated in 2012 and is headquartered in Shelton, Connecticut.

Industry
Biotechnology
Sector
Healthcare
Phone
203 221 7381
Website
https://intensitytherapeutics.com
Address
1 Enterprise Drive, Suite 430, Shelton, United States

Latest news

Stocktwits

mikejohns777 Oct 15, 11:55 AM
$INTS what is the excuse this time? 💩 stock headed toward another RS in 2027. Tax loss harvesting this November and December! $1.xx by end of December without a doubt if not at beginning of month!
0 replies
TNNSTrade Oct 13, 7:08 PM
$INTS someone bought a few shares. Interesting action. Or should we say, pre action. News coming soon 😁
1 replies
Atrain1189 Oct 13, 6:35 PM
$INTS hmm
0 replies
TNNSTrade Oct 8, 5:28 AM
$INTS don't worry about the daily action here. Once the delivery system and technology are validated, this will be worth a lot more. We have the right mission and outcomes to do great things for the world.
1 replies
joel12365 Oct 7, 6:58 PM
$INTS Did someone say last chance under 4 doller or am I dreaming ;)
0 replies
joel12365 Sep 29, 6:30 PM
$INTS recent drop due to q3 being nearly over both data sets not published yet and sarcoma hasnt been mentioned.. we will see
0 replies
mikejohns777 Sep 29, 3:13 AM
$INTS $20 soon! After stock drops to $0.50 and there is a 40 to 1 reverse split. 🗑️ 💩
1 replies
joel12365 Sep 25, 8:00 PM
$INTS 11 months in one channel this tight
0 replies